Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M858Revenue $M81.4Net Margin (%)-151.4Z-Score-3.3
Enterprise Value $M739EPS $-0.1Operating Margin %-283.1F-Score3
P/E(ttm))0Cash Flow Per Share $-0.6Pre-tax Margin (%)-151.4Higher ROA y-yN
Price/Book11.110-y EBITDA Growth Rate %-31.4Quick Ratio3.5Cash flow > EarningsY
Price/Sales24.95-y EBITDA Growth Rate %-60.9Current Ratio3.7Lower Leverage y-yY
Price/Cash Flow0y-y EBITDA Growth Rate %0ROA % (ttm)-15.9Higher Current Ratio y-yY
Dividend Yield %0Insider Buy (3m)0ROE % (ttm)-51.0Less Shares Outstanding y-yN
Payout Ratio %0Shares Outstanding M220ROI % (ttm)-11.9Gross Margin Increase y-yN

Gurus Latest Trades with ARNA

Number of guru portfolios checked: 84. (List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
ARNAKen Fisher 2013-12-31 Buy $4.08 - $6.66
($5.22)
$ 3.9-25%New holding, 11000 sh.11,000
ARNAMario Gabelli 2011-03-31 Sold Out $1.41 - $2.16
($1.7)
$ 3.9129%Sold Out0
ARNAMario Gabelli 2010-12-31 Buy $1.27 - $2.38
($1.58)
$ 3.9147%New holding, 13000 sh.13,000
ARNAGeorge Soros 2008-06-30 Sold Out -0.01%$4.67 - $6.92
($5.5)
$ 3.9-29%Sold Out0
ARNAGeorge Soros 2006-12-31 Sold Out -0.05%$12.95 - $17.39
($14.6)
$ 3.9-73%Sold Out0
ARNAGeorge Soros 2006-09-30 Add0.04%$9.23 - $12.22
($10.9)
$ 3.9-64%Add 266%55,000
ARNAGeorge Soros 2006-06-30 Buy 0.02%$10.54 - $15.58
($13.3)
$ 3.9-71%New holding, 15000 sh.15,000
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

ARNA is held by these Gurus:

Ticker Guru Name Portfolio Date* Current Shares % of Shares Outstanding % of Total Assets Managed Change from Last Holdings Holding History
ARNA Ken Fisher 2014-09-3011,00000
Premium Most recent portfolio changes are included for Premium Members only!


ARNA: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
LIEF JACKChairman, President and CEO 2014-07-01Sell223,525$5.85-33.33view
BELCHER DONALD DDirector 2014-06-27Sell2,473$5.85-33.33view
SPECTOR STEVEN WEVP, General Counsel & Sec 2014-05-12Sell45,000$7.05-44.68view
BELCHER DONALD DDirector 2014-05-06Sell4,176$7-44.29view
HIXSON HARRY F JRDirector 2014-04-22Sell36,900$6.31-38.19view
Nova Tina SusanDirector 2014-04-14Sell35,000$6.22-37.3view
BELCHER DONALD DDirector 2014-04-01Sell1,905$6.45-39.53view
SHANAHAN WILLIAM R JRSVP & Chief Medical Officer 2014-04-01Sell60,000$6.37-38.78view
SPECTOR STEVEN WEVP, General Counsel & Sec 2014-03-04Sell25,000$7.01-44.37view
LIEF JACKChairman, President and CEO 2014-01-17Sell100,000$7.81-50.06view

Press Releases about ARNA :

    Quarterly/Annual Reports about ARNA:

    News about ARNA:

    Articles On GuruFocus.com
    Revisiting Arena, Orexigen, And VIVUS: Shareholders Can Recoup Their Losses By Invest In MannKind Aug 19 2014 
    (ARNA) Initiated with a Buy, (ICLD, FONR) Strong Performance on Financial Results Nov 16 2013 
    WEEKLY CFO SELLS HIGHLIGHT: ZNGA, ARNA, JACK, TUMI, PANW Apr 07 2013 
    comment on ARNA Mar 15 2013 
    comment on ARNA Mar 02 2013 
    WEEKLY CFO SELLS HIGHLIGHT: QCOM, RA, ARNA, ATU, DGX, MSCC Oct 07 2012 
    Arena Facing Increased Pressure from Peers Apr 23 2012 
    Arena Could Dip If Lorcaserin Fails Again Apr 22 2012 
    Vivus Could Rocket on Success of Qnexa Apr 13 2012 
    These 4 Biotech Stocks Are a Buy Now Feb 08 2012 

    More From Other Websites
    Obesity Pill Upstart Orexigen Therapeutics Gaining on Rivals Dec 12 2014
    Lagardère Unlimited is the new Friends Arena operator Dec 08 2014
    ARENA PHARMACEUTICALS INC Files SEC form 8-K, Regulation FD Disclosure Dec 05 2014
    Michael Bublé officially launches Birmingham’s ‘Barclaycard Arena’ Dec 04 2014
    Arena Pharmaceuticals Issued Composition of Matter Patent by United States Patent and Trademark... Nov 25 2014
    Arena Pharmaceuticals Issued Composition of Matter Patent by United States Patent and Trademark... Nov 25 2014
    24 NOVDelta Lloyd Bank priced Arena 2014-II securitisation Nov 24 2014
    Arena Pharmaceuticals to Present at Piper Jaffray 26th Annual Healthcare Conference Nov 24 2014
    Arena Pharmaceuticals to Present at Piper Jaffray 26th Annual Healthcare Conference Nov 24 2014
    ARENA PHARMACEUTICALS INC Financials Nov 14 2014
    Arena Pharmaceuticals to Present at Stifel 2014 Healthcare Conference Nov 13 2014
    Arena Pharmaceuticals to Present at Stifel 2014 Healthcare Conference Nov 13 2014
    Arena Pharmaceuticals (ARNA) Shares March Higher, Can It Continue? Nov 13 2014
    10-Q for Arena Pharmaceuticals, Inc. Nov 08 2014
    ARENA PHARMACEUTICALS INC Files SEC form 10-Q, Quarterly Report Nov 06 2014
    Lorcaserin HCl Data to be Presented at the Annual Meeting of the American Association for the Study... Nov 06 2014
    Lorcaserin HCl Data to be Presented at the Annual Meeting of the American Association for the Study... Nov 06 2014
    Arena Pharmaceuticals to Present at Credit Suisse 2014 Healthcare Conference Nov 05 2014
    Arena Pharmaceuticals to Present at Credit Suisse 2014 Healthcare Conference Nov 05 2014
    Arena Pharmaceuticals Posts In Line Q3 Loss, Belviq Grows Nov 04 2014

    Add Notes, Comments

    If you want to ask a question, or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    Free 7-day Trial
    FEEDBACK